{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:22:27Z","timestamp":1777944147008,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41443-018-0027-5","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:54:36Z","timestamp":1537458876000},"page":"263-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient perspectives on Peyronie\u2019s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum"],"prefix":"10.1038","volume":"31","author":[{"given":"J.","family":"Kaminetsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gittelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. H.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","volume":"7","author":"AN Bilgutay","year":"2015","unstructured":"Bilgutay AN, Pastuszak AW. Peyronie\u2019s disease: a review of etiology, diagnosis, and management. Curr Sex Health Rep. 2015;7:117\u201331.","journal-title":"Curr Sex Health Rep"},{"key":"27_CR2","first-page":"142","volume":"5","author":"M Jalkut","year":"2003","unstructured":"Jalkut M, Gonzalez-Cadavid N, Rajfer J. Peyronie\u2019s disease: a review. Rev Urol. 2003;5:142\u20138.","journal-title":"Rev Urol"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/andr.292","volume":"3","author":"J Sullivan","year":"2015","unstructured":"Sullivan J, Moskovic D, Nelson C, Levine L, Mulhall J. Peyronie\u2019s disease: urologist\u2019s knowledge base and practice patterns. Andrology. 2015;3:260\u20134.","journal-title":"Andrology"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int. 2001;88:727\u201330.","journal-title":"BJU Int"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","volume":"11","author":"M Stuntz","year":"2016","unstructured":"Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of Peyronie\u2019s disease in the United States: a population-based study. PLoS ONE. 2016;11:e0150157.","journal-title":"PLoS One"},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.ijir.3900727","volume":"13","author":"EL Rhoden","year":"2001","unstructured":"Rhoden EL, Teloken C, Ting HY, Lucas ML, Teod\u00f3sio da Ros C, Ary Vargas, Souto C. Prevalence of Peyronie\u2019s disease in men over 50-y-old from Southern Brazil. Int J Impot Res. 2001;13:291\u20133.","journal-title":"Int J Impot Res"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie\u2019s disease. J Urol. 2006;175:2115\u20138.","journal-title":"J Urol"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/jsm.12202","volume":"10","author":"MR Farrell","year":"2013","unstructured":"Farrell MR, Corder CJ, Levine LA. Peyronie\u2019s disease among men who have sex with men: characteristics, treatment, and psychosocial factors. J Sex Med. 2013;10:2077\u201383.","journal-title":"J Sex Med"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","volume":"5","author":"CJ Nelson","year":"2008","unstructured":"Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie\u2019s disease. J Sex Med. 2008;5:1985\u201390.","journal-title":"J Sex Med"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/j.1743-6109.2008.00883.x","volume":"5","author":"R Rosen","year":"2008","unstructured":"Rosen R, Catania J, Lue T, Althof S, Henne J, Hellstrom W, et al. Impact of Peyronie\u2019s disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008;5:1977\u201384.","journal-title":"J Sex Med"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/j.1743-6109.2008.00949.x","volume":"5","author":"JF Smith","year":"2008","unstructured":"Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie\u2019s disease. J Sex Med. 2008;5:2179\u201384.","journal-title":"J Sex Med"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ijir.2012.48","volume":"25","author":"TJ Walsh","year":"2013","unstructured":"Walsh TJ, Hotaling JM, Lue TF, Smith JF. How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie\u2019s disease. Int J Impot Res. 2013;25:109\u201312.","journal-title":"Int J Impot Res"},{"key":"27_CR13","unstructured":"Xiaflex\u00ae (collagenase clostridium histolyticum) for injection, for intralesional use [package insert]. Malvern, PA: Endo Pharmaceuticals Inc.; 2018."},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","volume":"187","author":"M Gelbard","year":"2012","unstructured":"Gelbard M, Lipshultz LI, Tursi J, Smith T, Kaufman G, Levine LA. Phase 2b study of the clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie disease. J Urol. 2012;187:2268\u201374.","journal-title":"J Urol"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/0092623X.2016.1147511","volume":"43","author":"S Davis","year":"2016","unstructured":"Davis S, Ferrar S, Sadikaj G, Binik Y, Carrier S. Shame, catastrophizing, and negative partner responses are associated with lower sexual and relationship satisfaction and more negative affect in men with Peyronie\u2019s disease. J Sex Marital Ther. 2016;43:264\u201376.","journal-title":"J Sex Marital Ther"},{"key":"27_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10508-015-0568-3","volume":"45","author":"RC Rosen","year":"2016","unstructured":"Rosen RC, Heiman JR, Long JS, Fisher WA, Sand MS. Men with sexual problems and their partners: findings from the International Survey of Relationships. Arch Sex Behav. 2016;45:159\u201373.","journal-title":"Arch Sex Behav"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10508-010-9703-3","volume":"40","author":"JR Heiman","year":"2011","unstructured":"Heiman JR, Long JS, Smith SN, Fisher WA, Sand MS, Rosen RC. Sexual satisfaction and relationship happiness in midlife and older couples in five countries. Arch Sex Behav. 2011;40:741\u201353.","journal-title":"Arch Sex Behav"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","volume":"149","author":"MK Gelbard","year":"1993","unstructured":"Gelbard MK, James K, Riach P, Dorey F. Collagenase versus placebo in the treatment of Peyronie\u2019s disease: a double-blind study. J Urol. 1993;149:56\u201358.","journal-title":"J Urol"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/jsm.12731","volume":"12","author":"LA Levine","year":"2015","unstructured":"Levine LA, Cuzin B, Mark S, Gelbard MK, Jones NA, Liu G, et al. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie\u2019s disease: a phase 3 open-label study. J Sex Med. 2015;12:248\u201358.","journal-title":"J Sex Med"},{"key":"27_CR21","first-page":"163","volume":"11","author":"LD McLeod","year":"2011","unstructured":"McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharm Outcomes Res. 2011;11:163\u20139.","journal-title":"Expert Rev Pharm Outcomes Res"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0027-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0027-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0027-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:27:03Z","timestamp":1684618023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0027-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0027-5","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"19 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Kaminetsky reports serving as a consultant and on the speakers\u2019 bureau for AbbVie Pharmaceuticals, Auxilium Pharmaceuticals, Inc.; and being an investigator for AbbVie Pharmaceuticals, Antares Pharma, Inc, Auxilium Pharmaceuticals, Inc., Clarus Therapeutics, Eli Lilly and Company, and Lipocine Inc. Dr Gittelman has nothing to disclose. Drs Kaufman and Smith report being employees of Auxilium Pharmaceuticals, Inc., during the clinical study. Dr Jordan reports being an investigator for Auxilium Pharmaceuticals, Inc.; serving as a consultant for PNN Medical; and being a scientific board member for Precision Medical Devices. This study was funded by Auxilium Pharmaceuticals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}